Abstract:BACKGROUND:Von Hippel-Lindau (VHL) disease is an autosomal dominant hereditary tumor syndrome with an incidence of approximately 1/36,000. VHL disease-associated clear cell renal cell carcinoma (ccRCC) is the most common congenital RCC. Although recent advances in treating RCC have improved the long-term prognosis of patients with VHL disease, kidney cancer is still the leading cause of death in these patients. Therefore, finding new targets for diagnosing and treating VHL disease-associated ccRCC is still essential.METHODS:In this study, we collected matched tumor tissues and normal samples from 25 patients with VHL disease-associated ccRCC, diagnosed and surgically treated in the Department of Urology, Peking University First Hospital. After screening, we performed whole genome bisulfite sequencing (WGBS) on 23 pairs of tissues and RNA-seq on 6 pairs of tissues. And we also compared the VHL disease-associated ccRCC transcriptome data with the sporadic ccRCC transcriptome data from the The Cancer Genome Atlas (TCGA) public database RESULTS: We found that the methylation level of VHL disease-associated ccRCC tumor tissues was significantly lower than that of normal tissues. The tumor tissues showed a difference in the copy number of 3p loss and 5q and 7q gain compared with normal tissues. We integrated RNA-seq and WGBS data to reveal methylation candidate genes associated with VHL disease-associated ccRCC; our results showed 124 hypermethylated and downregulated genes, and 245 hypomethylated and upregulated genes. By comparing the VHL disease-associated ccRCC transcriptome data with the sporadic ccRCC transcriptome data from the TCGA public database, we found that the major pathways of differential gene enrichment differed between them.CONCLUSIONS:Our study mapped the multiomics of copy number variation, methylation and mRNA level changes in tumor and normal tissues of clear cell renal cell carcinoma with VHL syndrome, which provides a solid foundation for the mechanistic study, biomarker screening, and therapeutic target discovery of clear cell renal cell carcinoma.

Analysis of Two Single Nucleotide Polymorphisms in Von Hippel-Lindau Gene and Detection of Loss of Heterozygosity in Chinese Sporadic Renal Cell Carcinoma

Analysis of Two Single Nucleotide Polymorphisms and Loss of Heterozygosity Detection in the VHL Gene in Chinese Patients with Sporadic Renal Cell Carcinoma.

[Analysis of Biallelic Inactivation of the Von Hippel-Lindau Tumor Suppressor Gene VHL in Patients of Renal Cell Carcinoma Patient].

[Frequent Somatic Mutations of the Von Hippel-Lindau Tumor Suppressor Gene in Primary Sporadic Human Renal Clear Cell Carcinomas].

[Frequent Somatic Mutations of the Von Hippel-Lindau (VHL) Tumor Suppressor Gene and Its Meaning in Sporadic Human Renal Clear Cell Carcinoma].

A Clinical Analysis of Multilocular Cystic Renal Cell Carcinoma and Its Correlation with Mutation of the Von Hippel-Lindau Gene

Relationship between von Hipple-Lindau tumor suppressor gene mutations and the prognosis of Chinese sporadic clear cell renal cell carcinoma

Preliminary Study of Whole-Genome Bisulfite Sequencing and Transcriptome Sequencing in VHL Disease-Associated Ccrcc.

Higher Prevalence of Novel Mutations in VHL Gene in Chinese Von Hippel-Lindau Disease Patients.

[The Expression of Hypoxia Inducible Factor-1,2 Alpha in Sporadic Clear Cell Renal Cell Carcinoma and Their Relationships to the Mutations of Von Hippel-Lindau Gene].

Germline mutations in the VHL gene associated with 3 different renal lesions in a Chinese von Hippel-Lindau disease family

Natural History and Growth Kinetics of Clear Cell Renal Cell Carcinoma in Sporadic and Von Hippel-Lindau Disease.

[Mutation of Von Hippel-Lindau Gene and Expression of Vascular Endothelial Growth Factor in Sporadic Clear Cell Renal Cell Carcinoma and Their Relationships to Angiogenesis].

Genotype-phenotype Correlations in Chinese Von Hippel-Lindau Disease Patients

Frequent Mutations of VHL Gene and the Clinical Phenotypes in the Largest Chinese Cohort With Von Hippel-Lindau Disease.

Clinical and Genetic Analysis of the Von Hippel-Lindau (VHL) Gene in Two Chinese Pedigrees with VHL Syndrome

Natural History of Von Hippel-Lindau Disease-Associated and Sporadic Clear Cell Renal Cell Carcinoma: a Comparative Study

EP1.03-13 Molecular Characteristics of East Asian Patients with VHL-Mutated Non-Small-Cell Lung Cancer: A Retrospective Study

Distinctive Clinicopathological Features of Von Hippel-Lindau-associated Hereditary Renal Cell Carcinoma: A Single-Institution Study

Comparative Analysis of Renal Tumor Patients with Van Hippel-Lindau Disease and Those with Sporadic Renal Cell Cancers

Genome-Wide Profiling Of Chromosomal Alterations In Renal Cell Carcinoma Using High-Density Single Nucleotide Polymorphism Arrays